Investors, patients and activists, no doubt, hope they won't have to put out a mayday distress call, but as Dendrama's fate would have it, the company announced today that the Food and Drug Administration has assigned May Day as its decision day for the prostate cancer treatment Provenge.... Read More
When I do an interview with a clinical trial investigator I typically try to take care of what I call the "housekeeping" at the beginning or end... Read More